Boston, MA -- (SBWIRE) -- 09/16/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Promotora de Informaciones S.A. (NYSE:PRIS), Rockwell Medical Inc(NASDAQ:RMTI), Mercer International Inc. (NASDAQ:MERC), Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)
Promotora de Informaciones S.A. (NYSE:PRIS) shares jumped 27.19% and closed at $1.45 in the last trading session on no official news. The 52 week trading range for the company is $0.71 - $2.44. The shares of the company gained 59% in the last one year.
How Should Investors Trade PRIS After The Recent Volatility? Get Free Report Here
Rockwell Medical Inc(NASDAQ:RMTI) shares gained 22.82% to $10.11. The company on Sept. 4 said its lead experimental drug met the main goal of improving hemoglobin levels in its final late-stage trial among adult patients with chronic kidney disease. The study was the second of two identical late-stage studies testing the drug in patients with chronic kidney disease on hemodialysis — a process by which waste and extra fluid is removed from the blood of patients with kidney failure.
How Should Investors Trade RMTI After The Recent Volatility? Get Free Report Here
Mercer International Inc. (NASDAQ:MERC) shares gained 10.68% to $7.67. The company announced that Chairman, CEO and President Jimmy Lee and Executive Vice President, CFO and Secretary David Gandossi presented at the 2013 RBC Capital Markets' Global Industrials Conference on September 11, 2013 at 10:55 am at Mandarin Oriental Hotel.
Additionally, the company on August 1 reported results for the second quarter ended June 30, 2013. Operating EBITDA in the second quarter of 2013 was EURO14.0 million ($18.3 million), compared to EURO32.9 million ($42.2 million) in the second quarter of 2012 and EURO24.3 million ($32.1 million) in the first quarter of 2013.
Is MERC A Good Buy After The Recent Price Movement? Find Out Here
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) shares gained 9.16% to $5.48. On September 9, 2013, Idenix Pharmaceuticals implemented a restructuring of its operations at the Company’s headquarters in Cambridge, Massachusetts to reduce its workforce by approximately 15 positions in connection with the Company’s strategic initiatives to improve operational efficiencies and outsource certain research and development functions. The workforce reduction will occur in the quarter ending September 30, 2013. The Company continues to explore additional cost saving initiatives.
Is IDIX A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)